WebMarket Cap: 2.256B: Beta (5Y Monthly) 1.46: PE Ratio (TTM) N/A: EPS (TTM)-1.24: Earnings Date: May 01, 2024 - May 05, 2024: Forward Dividend & Yield: N/A (N/A) Ex-Dividend Date: N/A: 1y Target Est... WebAug 1, 2024 · TransMedics Group has a market capitalization of US$1.1b, so we would expect some institutional investors to have noticed the stock. Our analysis of the ownership of the company, below, shows...
TMDX - Transmedics Group Inc Stock quote - CNNMoney.com
WebGet the latest TransMedics Group, Inc. (TMDX) stock news and headlines to help you in your trading and investing decisions. ... Market Cap: 2.307B: Beta (5Y Monthly) 1.46: PE Ratio (TTM) N/A ... WebView the latest TransMedics Group Inc. (TMDX) stock price, news, historical charts, analyst ratings and financial information from WSJ. shipping ecommerce integration
What Kind Of Investors Own Most Of TransMedics Group, Inc. (NASDAQ:TMDX…
WebApr 8, 2024 · GRAN REPASO DEL MERCADO! Viendo el comportamiento del mercado desde antes del FTD hasta el día de hoy WebMar 28, 2024 · TMDX has a market cap or net worth of $2.40 billion as of March 29, 2024. Its market cap has increased by 271.81% in one year. Market Cap. 2.40B. Enterprise … WebTransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. CEO Waleed H. Hassanein Employees 212 Headquarters Andover, Massachusetts Founded 1998 TMDX Key Statistics Market cap 2.44B Price-Earnings ratio -60.82 Dividend yield — shipping economics